NCT00043459View on ClinicalTrials.gov

Study of T900607-Sodium in Previously Treated Patients With Non-Hodgkin's Lymphoma.

PHASE2TerminatedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

July 31, 2002

Study Completion Date

March 31, 2003

Conditions
Non-Hodgkin's Lymphoma
Interventions
DRUG

intravenous T900607-sodium

Trial Locations (5)

10021

Weill Medical College of Cornell University, New York

60611

Northwestern University, Chicago

60612

Rush Medical Center, Chicago

80010

University of Colorado Health Sciences Center, Aurora

92037

Scripps Health Center, La Jolla

Sponsors

Lead Sponsor

Tularik
All Listed Sponsors
lead

Tularik

INDUSTRY

NCT00043459 - Study of T900607-Sodium in Previously Treated Patients With Non-Hodgkin's Lymphoma. | Biotech Hunter | Biotech Hunter